Sublingual allergy immunotherapy tablet — Competitive Intelligence Brief

Sublingual allergy immunotherapy tablet (Sublingual allergy immunotherapy tablet) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Allergen immunotherapy. Area: Immunology.

phase 3 Allergen immunotherapy Immunology Biologic

Target snapshot

Sublingual allergy immunotherapy tablet (Sublingual allergy immunotherapy tablet) — ALK-Abelló A/S. Sublingual allergy immunotherapy tablets work by exposing the body to small amounts of an allergen to build up tolerance and reduce symptoms.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Sublingual allergy immunotherapy tablet TARGET	Sublingual allergy immunotherapy tablet	ALK-Abelló A/S	phase 3	Allergen immunotherapy
PURETHAL Grasses, 20.000 AUM/ml	PURETHAL Grasses, 20.000 AUM/ml	HAL Allergy	marketed	Allergen immunotherapy extract	Grass pollen allergens (IgE and T-cell epitopes)
wasp venom	wasp venom	Allergopharma GmbH & Co. KG	marketed	Allergen immunotherapy
Novel dose adjustment of Alutard SQ	Novel dose adjustment of Alutard SQ	Beijing Tongren Hospital	marketed	Allergen immunotherapy
PURETHAL Birch, 20.000 AUM/ml	PURETHAL Birch, 20.000 AUM/ml	HAL Allergy	marketed	Allergen immunotherapy extract	Birch pollen allergens (Bet v 1 and related proteins)
ragweed pollen	ragweed pollen	The University of Texas Medical Branch, Galveston	marketed	Allergen immunotherapy
AllerT	AllerT	Anergis	marketed	Allergen immunotherapy (peptide-based)	Allergen-derived peptide epitopes

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Allergen immunotherapy class)

1. Allergopharma GmbH & Co. KG · 8 drugs in this class
2. HAL Allergy · 2 drugs in this class
3. Medical University of Silesia · 2 drugs in this class
4. ALK-Abelló A/S · 2 drugs in this class
5. Laboratorios Leti, S.L. · 1 drug in this class
6. National Taiwan University Hospital · 1 drug in this class
7. Royal Sussex County Hospital · 1 drug in this class
8. The University of Texas Medical Branch, Galveston · 1 drug in this class
9. University of Genova · 1 drug in this class
10. Anergis · 1 drug in this class